Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1984 |
100 Clinical Results associated with Yangzhou Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Yangzhou Pharmaceutical Co., Ltd.
100 Deals associated with Yangzhou Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Yangzhou Pharmaceutical Co., Ltd.